Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cue Biopharma (CUE) Other Operating Expenses (2022 - 2025)

Cue Biopharma's Other Operating Expenses history spans 8 years, with the latest figure at $51000.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 152.04% year-over-year to $51000.0; the TTM value through Sep 2025 reached $47000.0, up 118.43%, while the annual FY2024 figure was $93000.0, 159.24% up from the prior year.
  • Other Operating Expenses for Q3 2025 was $51000.0 at Cue Biopharma, up from -$4000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $51000.0 in Q3 2025 and bottomed at -$258000.0 in Q2 2022.
  • The 5-year median for Other Operating Expenses is -$19000.0 (2021), against an average of -$60500.0.
  • The largest annual shift saw Other Operating Expenses tumbled 726.32% in 2023 before it surged 152.04% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $20000.0 in 2021, then crashed by 195.0% to -$19000.0 in 2022, then crashed by 726.32% to -$157000.0 in 2023, then soared by 97.45% to -$4000.0 in 2024, then skyrocketed by 1375.0% to $51000.0 in 2025.
  • Per Business Quant, the three most recent readings for CUE's Other Operating Expenses are $51000.0 (Q3 2025), -$4000.0 (Q4 2024), and -$98000.0 (Q3 2024).